Chiropractors in Ashland, MO Accepting Medicare
6 Chiropractors found. Showing 1 - 6
 Ashland Chiropractic, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 305 E Broadway, Suite B, Ashland, MO 65010 Phone: 573-657-8300 |
Enjoy Great Health Chiropractic, Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 305 East Broadway, Suite C, Ashland, MO 65010 Phone: 573-657-2211 |
 Dr. Janice Sines, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 305 E Broadway, Suite #b, Ashland, MO 65010 Phone: 573-657-8300 |
Natalie Bill Dowd, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 101 Redtail Dr Ste A, Ashland, MO 65010 Phone: 573-673-8558 |
Natalie Bill Dowd, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 406 S Main St, Ashland, MO 65010 Phone: 573-657-3569 Fax: 573-657-3569 |
 Gary Sines, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 305 E Broadway, Suite B, Ashland, MO 65010 Phone: 573-657-8300 |
News Archive
Researchers explore role of stem cells in treating neuroinjury and neurodegenerative disorders
Researchers at the University of Florida, USA, led by Dr. K. Wang have demonstrated that inhibition of Rho-associated kinase (ROCK) and subsequent cofilin dephosphorylation is mediating neurite outgrowth in PC12 cells.
Poor children with epilepsy have less favorable social outcomes as adults, study finds
In a population-based Canadian study of children with epilepsy, each of whom had access to universal health care, those from poor families had the same medical course and remission rate as their wealthier counterparts, but they had a less favorable social outcome as adults.
Identification of early ovarian cancer symptoms may have important clinical implications
Symptoms experienced by women that are more severe or frequent than expected and of recent occurrence warrant further diagnostic investigation because they are more likely to be associated with both benign (non-cancerous) and malignant (cancerous) ovarian masses
FDA issues complete response letter regarding the NDA for carisbamate
The U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for carisbamate, an anti-epileptic drug in development, announced Ortho-McNeil-Janssen Pharmaceuticals, Inc.
› Verified 5 days ago
Speech-Language Pathologists
Chiropractors
Physical Therapists
Occupational Therapists